A Multicenter, Randomized, Double-Blind, Parallel-Group,

Project: Research project

Project Details

Description

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-la (BIIB017) in Subjects with Relapsing Multiple Sclerosis
StatusFinished
Effective start/end date5/1/093/31/13

Funding

  • BIOGEN INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.